Search company, investor...

Founded Year



Corporate Minority - P2P | Alive

Total Raised




Last Raised

$47.08M | 1 yr ago

About BICO

BICO is a biotechnology company. It offers bioinks, bioprinters, and services that enable 3-D cell culturing, tissue engineering, and drug development. The company produces on-demand bioprinting of human organs and tissues, future reality, and future health. It is based in Gothenburg, Sweden.

Headquarters Location

Långfilsgatan 9

Gothenburg, 412 77,




Expert Collections containing BICO

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

BICO is included in 1 Expert Collection, including Drug Discovery Tech Market Map.


Drug Discovery Tech Market Map

221 items

This CB Insights Tech Market Map highlights 220 drug discovery companies that are addressing 12 distinct technology priorities that pharmaceutical companies face.

BICO Patents

BICO has filed 42 patents.

The 3 most popular patent topics include:

  • electrical engineering
  • mechanical power transmission
  • 3d printing
patents chart

Application Date

Grant Date


Related Topics




Transcription factors, Biomaterials, Cell biology, Polymers, Clusters of differentiation


Application Date


Grant Date



Related Topics

Transcription factors, Biomaterials, Cell biology, Polymers, Clusters of differentiation



Latest BICO News

BICO divests Ginolis through management buy-out

Nov 21, 2023

BICO divests Ginolis through management buy-out 21 November 2023 × Signing agreement The transaction is estimated to result in a divestment loss of SEK 25m, which is a non-cash item. Final divestment result will be reported and disclosed in the Q4 report. IP-rights and licenses related to the patented PMBi dispensing pump has been carved out from the transaction and transferred to BICO. Ginolis House will also be carved-out from the transaction. Closing of Ginolis House is subject to establishment of a Finnish entity with real estate VAT registration at the Finnish tax authorities. BICO is entitled to 70% of net proceeds if the company is sold within three years after closing. The rationale behind the divestment is that the company has not transitioned fast enough to mitigate the post-pandemic downturn. Ginolis has been right sized during 2023, but order intake has not been restored according to expectations.

BICO Frequently Asked Questions (FAQ)

  • When was BICO founded?

    BICO was founded in 2016.

  • Where is BICO's headquarters?

    BICO's headquarters is located at Långfilsgatan 9, Gothenburg.

  • What is BICO's latest funding round?

    BICO's latest funding round is Corporate Minority - P2P.

  • How much did BICO raise?

    BICO raised a total of $760K.

  • Who are the investors of BICO?

    Investors of BICO include Sartorius and Horizon 2020.

  • Who are BICO's competitors?

    Competitors of BICO include Inventia Life Science and 3 more.


Compare BICO to Competitors

Mediq Logo

Mediq is a company focused on healthcare and homecare, operating within the medical devices and healthcare services industry. The company provides medical devices, healthcare products, and innovative solutions to healthcare professionals and patients, with a particular emphasis on supporting those with chronic conditions. Mediq's services range from supplying medical devices and supplementary care to providing education and 24-hour support, catering to both homecare settings and healthcare institutions such as hospitals and nursing homes. It was founded in 1899 and is based in De Meern, Netherlands.

UPM Biomedicals

UPM Biomedicals develops and supplies sustainable wood-based biomedical products for a variety of uses. Its high-quality products are derived from renewable wood sources originating from sustainably managed and certified forests.


Mehilainen focuses on providing social and healthcare services. The company offers a wide range of medical and health services, including general care and specialized treatments. Mehilainen primarily serves the Healthcare sector. It was founded in 1909 and is based in Helsinki, Finland.

Q5D Technology

Q5D develops robotic machinery to add electrical functions to products in aerospace, automotive, and many other industries. The company offers polymer end effectors, wiring end effectors, CY1000 5-axis manufacturing platforms, conductive track end effectors, and more. It was founded in 2018 and is based in Bristol, United Kingdom.

Optomec Logo

Optomec is a company that specializes in additive manufacturing, operating within the 3D printing and electronics industries. The company offers 3D printing solutions for metals and electronics, providing the ability to print electronics directly onto 3D surfaces and to fabricate, enhance, and repair high-performance metal components. Optomec primarily serves sectors such as electronics, energy, life sciences, the Internet of Things, and aerospace. It was founded in 2014 and is based in Albuquerque, New Mexico.


Komax is a globally active technology group specializing in automation solutions for selected processes. With its innovative and high-quality solutions for the wire processing industry, Komax helps its customers implement economical and safe manufacturing processes, especially in the automotive supply sector. Komax offers a comprehensive range of automated, intelligent processing solutions for all wire processing applications. Standardized and customer-specific systems are supplemented by an extensive range of quality assurance modules, testing devices, and networking solutions for the reliable and efficient production of wire harnesses.


CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.